Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 88104: Cytopathology Smear Preparation and Interpretation
CPT-88106-NON-GYNECOLOGIC-CYTOPATHOLOGY-SMEAR-SIMPLE-FILTERCPT 88106: Cytopathology Smear of Non-Cervical Fluids
CPT-88108-CYTOPATHOLOGY-FLUID-SMEAR-CONCENTRATION-TECHNIQUECPT 88108: Cytopathology Concentration Smear Preparation and Interpretation
CPT-88112-LIQUID-BASED-CYTOPATHOLOGY-SELECTIVE-CELLULAR-ENHANCEMENTCPT 88112: Selective Cellular Enhancement for Cytopathology
CPT-88120-URINARY-TRACT-IN-SITU-HYBRIDIZATION-MORPHOMETRIC-ANALYSISCPT 88120: In Situ Hybridization on Urinary Tract Specimen, 3–5 Probes
CPT-88121-URINARY-TRACT-IN-SITU-HYBRIDIZATION-MORPHOMETRYCPT 88121: Urine In Situ Hybridization with 3–5 Probes
CPT-88125-FORENSIC-CYTOPATHOLOGY-TECHNICAL-SERVICECPT 88125: Cytopathology Specimen Analysis for Forensic Testing
CPT-88130-SEX-CHROMATIN-BARR-BODY-ANALYSISCPT 88130: Sex Chromatin (Barr Body) Analysis
CPT-88140-PERIPHERAL-BLOOD-SMEAR-SEX-CHROMATIN-IDENTIFICATIONCPT 88140: Peripheral Blood Smear for Sex Chromatin Identification
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.